Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma
- 1 June 1998
- journal article
- research article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 21 (6) , 358-364
Abstract
Medullary thyroid carcinoma (MTC) may occur either as a sporadic or familial (FMTC) disease. Multiple endocrine neoplasia (MEN) type 2, inherited as an autosomal dominant disease, is characterized by coexistence of MTC with other endocrine neoplasia. Activating mutations of the RET proto-oncogene, involving the somatic or the germinal cell lineage, are found in both inherited and acquired forms. In this study, RET mutations were screened in 47 individuals either affected by MTC or belonging to families with hereditary MTC. Exons 10, 11, 13, 14, 15 and 16 of the RET gene were amplified by polymerase chain reaction and examined by DNA sequence and/or restriction enzyme analysis to detect mutations in purified amplicons. Six MEN 2A families with a germline mutation at codon 634, one FMTC family carrying a mutation at codon 618 and two MEN 2B families with a mutation at codon 918 were identified. In affected members of a MEN 2A family no known RET mutations were observed. Besides, we identified a germline mutation in a patient with apparently sporadic MTC and in two out of three sons, indicating the presence of a sporadic misclassified familial disease. In all of the families examined we were able to distinguish the affected vs unaffected (not at risk) members. A somatic mutation of codon 918 was detected in three out of ten patients with apparently sporadic MTC.Keywords
This publication has 22 references indexed in Scilit:
- Multiple endocrine neoplasia types 1 and 2Current Opinion in Endocrinology, Diabetes and Obesity, 1997
- Molecular genetics and clinical implications of medullary thyroid carcinoma and mutations of the RET protooncogeneCurrent Opinion in Endocrinology, Diabetes and Obesity, 1996
- Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of theRET proto-oncogeneInternational Journal of Cancer, 1996
- Somatic mutations in the RET proto‐oncogene in sporadic medullary thyroid carcinomaClinical Endocrinology, 1996
- Early treatment of hereditary medullary thyroid carcinoma after attribution of multiple endocrine neoplasia type 2 gene carrier status by screening for ret gene mutationsSurgery, 1995
- Low frequency of germline mutations in the RET proto‐oncogene in patients with apparently sporadic medullary thyroid carcinomaClinical Endocrinology, 1995
- Clinical Screening as Compared with DNA Analysis in Families with Multiple Endocrine Neoplasia Type 2ANew England Journal of Medicine, 1994
- Predictive DNA Testing and Prophylactic Thyroidectomy in Patients at Risk for Multiple Endocrine Neoplasia Type 2AAnnals of Surgery, 1994
- Familial medullary thyroid carcinoma without associated endocrinopathies: A distinct clinical entityBritish Journal of Surgery, 1986
- Genetic Aspects of Multiple Endocrine NeoplasiaAnnual Review of Medicine, 1984